Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: Results of follow up to 30 months post-transplant

Clinical Transplantation

Volumn 21, Issue 3, 2007, Pages 295-300

  Mourad, Georges ^a   Karras, Alexandre ^b,o   Kamar, Nassim ^c   Garrigue, Valérie ^a   Legendre, Christophe ^b   Lefrançois, Nicole ^d   Charpentier, Bernard ^e   Bourbigot, Bernard ^f   Pouteil Noble, Claire ^g   Bayle, François ^h   Lebranchu, Yvon ⁱ   Mariat, Christophe ^j   Le Meur, Yann L ^k   Kessler, Michèle ^l   Moulin, Bruno ^m   Ducloux, Didier ⁿ   Delahousse, Michel ^o   Lang, Philippe ^p   Merville, Pierre ^q   Chaouche Teyara, Kamel ^r   Rostaing, Lionel ^c   more..

^a LAPEYRONIE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CHU RANGUEIL   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e BICÊTRE HOSPITAL   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h HÔPITAL MICHALLON   (France)

ⁱ CHU BRETONNEAU   (France)

^j HÔPITAL NORD   (France)

^k DUPUYTREN UNIVERSITY HOSPITAL   (France)

^l CHU NANCY BRABOIS   (France)

^m HÔPITAL CIVIL   (France)

ⁿ HÔPITAL SAINT JACQUES   (France)

^o FOCH HOSPITAL   (France)

^p HENRI MONDOR HOSPITAL   (France)

^q HÔPITAL PELLEGRIN   (France)

^r Laboratoires Novartis France   (France)

more..

Author keywords

Delayed cyclosporine administration; Delayed graft function; Enteric coated mycophenolate sodium

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID; STEROID;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADULT; ANEMIA; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EARLY INTERVENTION; ENTERIC COATED TABLET; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; ISCHEMIC COLITIS; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; MONOCLONAL IMMUNOGLOBULINEMIA; MORTALITY; NEPHROTOXICITY; NEUTROPENIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PYELONEPHRITIS; RECOMMENDED DRUG DOSE; RENAL GRAFT DYSFUNCTION; REVIEW; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THERAPY DELAY; THYROID CANCER; TRANSITIONAL CELL CARCINOMA; URINARY TRACT INFECTION;

CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TABLETS, ENTERIC-COATED; TIME FACTORS;

EID: 34248170252     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00660.x     Document Type: Review

References (21)

1. Hariharan S, Johnson CP, Besnahan BA, Taranto SE, McI ntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988-96. N Engl J Med 2000: 342: 605.
2. Meier-Kriesche H-U, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004: 4: 378.
3. Quiroga I, McShane P, Koo DD et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006: 21: 689.
4. Salvadori M, Rosati A, Bock A et al. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 2006: 81: 202.
5. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002: 62: 311.
6. Tanaka T, Takahara S, Hatori M et al. The differences between late graft loss group and long-term graft survival group in renal transplantation. Clin Transplant 2001: 15 (Suppl. 5): 16.
7. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000: 58: 859.
8. Dominguez J, Gonzalez A, Crossley N, Norambuena R. Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels. Transplant Proc 2004: 36: 1655.
9. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: Etiology, management and long-term significance. J Urol 1996: 155: 1831.
10. Koning OH, Ploeg RJ, van Bockel JH et al. Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997: 63: 1620.
11. Geddes CC, Woo YM, Jardine AG. The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol 2002: 15: 17.
12. Grundmann R, Hesse U, Wienand P, Baldamus C, Arns W. Graft survival and long-term renal function after sequential conventional cyclosporine A therapy in cadaver kidney transplantation - a prospective randomized trial. Klin Wochenschr 1987: 65: 879.
13. Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ. Timing of cyclosporine administration in patients with delayed graft function. J Surg Res 1987: 43: 489.
14. C ravedi P, C odreanu I, S atta A et al. Cyclosporine prolongs delayed graft function in kidney transplantation: Are rabbit anti-human thymocyte globulins the answer? Nephron Clin Pract 2005: 101: 65.
15. Silva LA, Felipe CR, Park SI et al. Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function. Braz J Med Biol Res 2006: 39: 43.
16. Kamar N, Garrigue V, Karras A et al. Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: A randomized, multicenter study. Am J Transplant 2006: 6: 1042.
17. United States Renal Data System. Researcher's Guide to the USRDS Database. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1998.
18. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976: 16: 31.
20. Andres A, Marcen R, Sanchez J et al. Comparative study of three different patterns of immunosuppression based on induction with basiliximab and low initial doses or delayed initiation of Neoral in kidney transplant recipients at high risk of delayed graft function. Am J Transplant 2005: 5 (Suppl.11): 570.
21. Kovarik J, Wolf P, Cisterne JM et al. Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts. Transplantation 1997: 64: 1701.